249 related articles for article (PubMed ID: 18342566)
1. Cellular roles of ADAM12 in health and disease.
Kveiborg M; Albrechtsen R; Couchman JR; Wewer UM
Int J Biochem Cell Biol; 2008; 40(9):1685-702. PubMed ID: 18342566
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.
Stautz D; Wewer UM; Kveiborg M
PLoS One; 2012; 7(5):e37628. PubMed ID: 22662180
[TBL] [Abstract][Full Text] [Related]
3. Targeting ADAM12 in human disease: head, body or tail?
Jacobsen J; Wewer UM
Curr Pharm Des; 2009; 15(20):2300-10. PubMed ID: 19601832
[TBL] [Abstract][Full Text] [Related]
4. Cell-surface metalloprotease ADAM12 is internalized by a clathrin- and Grb2-dependent mechanism.
Stautz D; Leyme A; Grandal MV; Albrechtsen R; van Deurs B; Wewer U; Kveiborg M
Traffic; 2012 Nov; 13(11):1532-46. PubMed ID: 22882974
[TBL] [Abstract][Full Text] [Related]
5. Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity.
Albrechtsen R; Stautz D; Sanjay A; Kveiborg M; Wewer UM
Exp Cell Res; 2011 Jan; 317(2):195-209. PubMed ID: 20951132
[TBL] [Abstract][Full Text] [Related]
6. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
[TBL] [Abstract][Full Text] [Related]
7. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
Fröhlich C; Klitgaard M; Noer JB; Kotzsch A; Nehammer C; Kronqvist P; Berthelsen J; Blobel C; Kveiborg M; Albrechtsen R; Wewer UM
Biochem J; 2013 May; 452(1):97-109. PubMed ID: 23458101
[TBL] [Abstract][Full Text] [Related]
8. ADAM12: a potential target for the treatment of chronic wounds.
Harsha A; Stojadinovic O; Brem H; Sehara-Fujisawa A; Wewer U; Loomis CA; Blobel CP; Tomic-Canic M
J Mol Med (Berl); 2008 Aug; 86(8):961-9. PubMed ID: 18604515
[TBL] [Abstract][Full Text] [Related]
9. ADAM12 is a four-leafed clover: the excised prodomain remains bound to the mature enzyme.
Wewer UM; Mörgelin M; Holck P; Jacobsen J; Lydolph MC; Johnsen AH; Kveiborg M; Albrechtsen R
J Biol Chem; 2006 Apr; 281(14):9418-22. PubMed ID: 16455653
[TBL] [Abstract][Full Text] [Related]
10. ADAM12-S stimulates bone growth in transgenic mice by modulating chondrocyte proliferation and maturation.
Kveiborg M; Albrechtsen R; Rudkjaer L; Wen G; Damgaard-Pedersen K; Wewer UM
J Bone Miner Res; 2006 Aug; 21(8):1288-96. PubMed ID: 16869727
[TBL] [Abstract][Full Text] [Related]
11. A disintegrin and metalloproteinase 12 (ADAM12) localizes to invasive trophoblast, promotes cell invasion and directs column outgrowth in early placental development.
Aghababaei M; Perdu S; Irvine K; Beristain AG
Mol Hum Reprod; 2014 Mar; 20(3):235-49. PubMed ID: 24243624
[TBL] [Abstract][Full Text] [Related]
12. ADAM12 localizes with c-Src to actin-rich structures at the cell periphery and regulates Src kinase activity.
Stautz D; Sanjay A; Hansen MT; Albrechtsen R; Wewer UM; Kveiborg M
Exp Cell Res; 2010 Jan; 316(1):55-67. PubMed ID: 19769962
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic processing of delta-like 1 by ADAM proteases.
Dyczynska E; Sun D; Yi H; Sehara-Fujisawa A; Blobel CP; Zolkiewska A
J Biol Chem; 2007 Jan; 282(1):436-44. PubMed ID: 17107962
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein.
Dyczynska E; Syta E; Sun D; Zolkiewska A
Int J Cancer; 2008 Jun; 122(11):2634-40. PubMed ID: 18241035
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
[TBL] [Abstract][Full Text] [Related]
16. RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.
Bourd-Boittin K; Le Pabic H; Bonnier D; L'Helgoualc'h A; Théret N
J Biol Chem; 2008 Sep; 283(38):26000-9. PubMed ID: 18621736
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate regulates ADAM12 through a molecular switch mechanism.
Sørensen HP; Vivès RR; Manetopoulos C; Albrechtsen R; Lydolph MC; Jacobsen J; Couchman JR; Wewer UM
J Biol Chem; 2008 Nov; 283(46):31920-32. PubMed ID: 18801731
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid-induced ADAM12 expression mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth.
Do EK; Kim YM; Heo SC; Kwon YW; Shin SH; Suh DS; Kim KH; Yoon MS; Kim JH
Int J Biochem Cell Biol; 2012 Nov; 44(11):2069-76. PubMed ID: 22903068
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12.
Qi Y; Duhachek-Muggy S; Li H; Zolkiewska A
PLoS One; 2014; 9(3):e92536. PubMed ID: 24651654
[TBL] [Abstract][Full Text] [Related]
20. Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.
Miller MA; Moss ML; Powell G; Petrovich R; Edwards L; Meyer AS; Griffith LG; Lauffenburger DA
Sci Rep; 2015 Oct; 5():15150. PubMed ID: 26477568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
